TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Balance Sheet
As of 2026-06-30 (10-Q), TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) reported total assets of $39.9B, total liabilities of $32.1B and shareholders' equity of $7.8B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $3.7B. Long-term debt: $16.6B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TEVATEVA PHARMACEUTICAL INDUSTRIES LTDFollow TEVA — free
—
Price chart with a free account
- Market cap
- 45.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2008 Dec 08 | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.85 | 2.00 | 1.25 | 1.10 | 2.88 | 1.04 | 2.23 | 6.95 | 0.99 | 0.96 | 1.78 | 1.98 | 2.18 | 2.17 | 2.80 | 3.23 | 3.30 | 3.56 | 3.66 | |
| Short-term investments | 0.05 | 0.25 | 0.04 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Receivables | 4.65 | 5.02 | 5.48 | 6.21 | 5.57 | 5.34 | 5.41 | 5.35 | 7.52 | 7.13 | 5.82 | 5.68 | 4.58 | 4.53 | 3.70 | 3.41 | 3.06 | 3.71 | 3.49 | |
| Inventory | 3.40 | 3.33 | 3.87 | 5.01 | 5.50 | 5.05 | 4.37 | 3.97 | 4.95 | 4.92 | 4.73 | 4.42 | 4.40 | 3.82 | 3.83 | 4.02 | 3.01 | 3.18 | 3.22 | |
| Current assets | 11.43 | 12.04 | 12.04 | 14.45 | 16.36 | 13.72 | 14.40 | 18.40 | 17.23 | 15.38 | 13.79 | 13.46 | 13.01 | 12.57 | 12.05 | 12.49 | 12.55 | 13.95 | 13.76 | |
| Total assets | 32.92 | 33.21 | 38.15 | 50.14 | 50.61 | 47.51 | 46.42 | 54.23 | 93.06 | 70.62 | 60.68 | 57.47 | 50.64 | 47.67 | 44.01 | 43.48 | 39.33 | 40.75 | 39.86 | |
| Current liabilities | 8.48 | 7.50 | 9.69 | 13.68 | 12.89 | 11.97 | 12.29 | 13.01 | 18.49 | 17.92 | 14.32 | 13.67 | 13.16 | 11.03 | 11.47 | 12.25 | 12.80 | 13.46 | 15.65 | |
| Long-term debt | — | 4.06 | 4.80 | 11.39 | 14.14 | 11.20 | 8.29 | 8.18 | 27.27 | 28.37 | 28.48 | 26.50 | 25.49 | 23.12 | 21.27 | 19.89 | 17.82 | 16.85 | 16.65 | |
| Short-term debt | 2.91 | 0.66 | 1.43 | 4.28 | 3.01 | 1.80 | 1.76 | 1.59 | 3.28 | 3.65 | 2.22 | 2.35 | 3.19 | 1.43 | 2.09 | 1.65 | 1.76 | 1.80 | 4.50 | |
| Total liabilities | 16.48 | 13.95 | 16.15 | 27.80 | 27.74 | 24.87 | 23.07 | 24.31 | 58.06 | 51.87 | 44.89 | 42.41 | 39.58 | 36.42 | 35.41 | 35.35 | 33.61 | 32.83 | 32.10 | |
| Shareholders' equity | 16.38 | 19.22 | 21.95 | 22.20 | 22.77 | 22.57 | 23.31 | 29.77 | 33.34 | 17.36 | 14.71 | 13.97 | 10.03 | 10.28 | 7.80 | 7.51 | 5.37 | 7.91 | 7.75 |
USD billions · SEC XBRL
TEVA PHARMACEUTICAL INDUSTRIES LTD — questions
- How much cash does TEVA PHARMACEUTICAL INDUSTRIES LTD have?
- $3.7B in cash and cash equivalents as of 2026-06-30.
- How much debt does TEVA PHARMACEUTICAL INDUSTRIES LTD have?
- $16.6B of long-term debt and $4.5B due within a year as of 2026-06-30.
- What are TEVA PHARMACEUTICAL INDUSTRIES LTD's total assets?
- $39.9B as of 2026-06-30.
- What is TEVA PHARMACEUTICAL INDUSTRIES LTD's shareholders' equity?
- $7.8B as of 2026-06-30.
Every figure on this page comes from TEVA PHARMACEUTICAL INDUSTRIES LTD's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.